Profile
Molly Cameron is currently the Director of Corporate Communications at Marinus Pharmaceuticals, Inc. She previously worked as the Manager of Media & Corporate Communications at Orchard Therapeutics Plc.
Molly Cameron active positions
| Companies | Position | Start |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Public Communications Contact | - |
Former positions of Molly Cameron
| Companies | Position | End |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Public Communications Contact | 01/04/2021 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Molly Cameron
